Oklahoma Governor Kevin Stitt signed legislation on Tuesday that increases the monthly sales cap for direct raw milk from dairy producers from 100 gallons to 1,500 gallons. The law also permits farmers to advertise their raw-dairy products directly on their farms.
Stitt, a Republican nearing the end of his second term as governor, is a strong supporter of Health and Human Services Secretary Robert F. Kennedy Jr.’s Make America Health Again movement. He celebrated the bill’s signing in a social media video while drinking a glass of milk, stating: “To all the raw milk-drinkers out there: Fantastic. Tastes like freedom.”
State Senator Jonathan Wingard, who co-sponsored the legislation, said the law empowers Oklahomans to make informed decisions without government interference and provides small family farms with new opportunities to expand their businesses. “This will make it easier for consumers to find and support local dairies that sell raw milk,” he added. “Raising the sales limit on raw milk and legalizing advertising of this particular product gives consumers the freedom to make their own dietary choices while providing new opportunities for dairy producers.”
The bill sailed through the House of Representatives and unanimously passed the Oklahoma Senate. However, another measure addressing commercial milk regulations—Senate Bill 2071—did not reach Stitt’s desk.
Senate Bill 2071 would have aligned state milk regulations with U.S. Food and Drug Administration standards. The FDA reviews Oklahoma’s food safety division for compliance with federal rules governing milk from all hoofed animals every few years. In past reviews, state agriculture officials reported that the FDA recommended Oklahoma update its regulations to match federal requirements.
Without changes, state officials warned that Oklahoma could lose its Grade A status—a designation allowing milk products to leave the state. Bryce Boyer, ODAFF’s director of communications, noted that the department appreciates the legislature’s consideration of Senate Bill 2071 and looks forward to a decision from the FDA.
